Access
To read this story in full you will need to login or make a payment (see right).
News
Nature 401, 631 (14 October 1999) | doi:10.1038/44238
Open Innovation Challenges
- More Challenges
- Powered by:
nature jobs
Associate Scientific Manager / Scientific Manager-Organic / Medicinal Chemistry
- Syngene International
- Bangalore, Karnataka 560099 India
Clinical Trial Analyst
- Indegene Lifesystems Pvt. Ltd
- Bengaluru 560 071 India
UK government not convinced by claims for flu drug
Natasha Loder
The UK government agreed last week that physicians should be discouraged from prescribing a novel anti-viral drug, Relenza, on the grounds that it is not convinced of the drug's cost-effectiveness.The government's announcement endorsed advice to physicians from the newly created National Institute of Clinical Excellence (NICE), set up to provide guidance on whether new therapies should be introduced into the health service.
To read this story in full you will need to login or make a payment (see right).
